Nishizawa Y - Search Results

1

Impact of initial therapy on survival in recurrent breast cancer.

Shiba E, Koyama H, Noguchi S, Nishizawa Y, Iwanaga T, Terasawa T. Shiba E, et al. Among authors: nishizawa y. Oncology. 1989;46(2):74-7. doi: 10.1159/000226688. Oncology. 1989. PMID: 2496368

2

[Combination therapy with 5'DFUR and MPA as a second line treatment for advanced/recurrent breast cancer].

Koyama H, Nishizawa Y, Noguchi S, Yamamoto H, Miyauchi K, Inaji H, Imaoka S, Iwanaga T. Koyama H, et al. Among authors: nishizawa y. Nihon Gan Chiryo Gakkai Shi. 1990 Mar 20;25(3):655-61. Nihon Gan Chiryo Gakkai Shi. 1990. PMID: 2141052 Japanese.

3

Influence of adjuvant chemotherapy for operable breast cancer on results of treatment at relapse.

Noguchi S, Miyauchi K, Nishizawa Y, Imaoka S, Koyama H, Iwanaga T. Noguchi S, et al. Among authors: nishizawa y. Oncology. 1989;46(2):69-73. doi: 10.1159/000226687. Oncology. 1989. PMID: 2710479

4

[Tamoxifen therapy in locally advanced primary and recurrent breast cancer (author's transl)].

Wada T, Koyama H, Takahashi Y, Nishizawa Y, Iwanaga T, Aoki Y, Terasawa T. Wada T, et al. Among authors: nishizawa y. Nihon Gan Chiryo Gakkai Shi. 1979 Aug 20;14(5):819-24. Nihon Gan Chiryo Gakkai Shi. 1979. PMID: 501187 Japanese. No abstract available.

5

[Carcinoma of male breast--with special reference to noninvasive carcinoma].

Tahara H, Koyama H, Noguchi S, Nishizawa Y, Iwanaga T, Iijima S, Hatanaka T, Ohtsuru M, Kuriyama H, Higashiyama N. Tahara H, et al. Among authors: nishizawa y. Nihon Gan Chiryo Gakkai Shi. 1989 Mar 20;24(3):585-91. Nihon Gan Chiryo Gakkai Shi. 1989. PMID: 2549134 Japanese.

6

Endogenous secretory receptor for advanced glycation end-products and cardiovascular disease in end-stage renal disease.

Nishizawa Y, Koyama H. Nishizawa Y, et al. J Ren Nutr. 2008 Jan;18(1):76-82. doi: 10.1053/j.jrn.2007.10.016. J Ren Nutr. 2008. PMID: 18089449 Review.

7

Platelet in progression of atherosclerosis: a potential target in diabetic patients.

Koyama H, Nishizawa Y. Koyama H, et al. Among authors: nishizawa y. Curr Diabetes Rev. 2005 May;1(2):159-65. doi: 10.2174/1573399054022758. Curr Diabetes Rev. 2005. PMID: 18220591 Review.

8

AGEs/RAGE in CKD: irreversible metabolic memory road toward CVD?

Koyama H, Nishizawa Y. Koyama H, et al. Among authors: nishizawa y. Eur J Clin Invest. 2010 Jul;40(7):623-35. doi: 10.1111/j.1365-2362.2010.02298.x. Epub 2010 May 21. Eur J Clin Invest. 2010. PMID: 20497213 Review.

9

Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer.

Koyama H, Wada T, Nishizawa Y, Iwanaga T, Aoki Y. Koyama H, et al. Among authors: nishizawa y. Cancer. 1977 Apr;39(4):1403-9. doi: 10.1002/1097-0142(197704)39:4<1403::aid-cncr2820390408>3.0.co;2-8. Cancer. 1977. PMID: 851940

10

Endogenous Secretory RAGE as a Novel Biomarker for Metabolic Syndrome and Cardiovascular Diseases.

Koyama H, Yamamoto H, Nishizawa Y. Koyama H, et al. Among authors: nishizawa y. Biomark Insights. 2007 Sep 17;2:331-9. Biomark Insights. 2007. PMID: 19662215 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,353 results

Search Page

Filters